Literature DB >> 3094050

Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland.

S Batra, A Biörklund.   

Abstract

The binding kinetics of tritiated quinuclidinyl benzilate (QNB) were studied in membrane preparations from human parotid and rabbit submandibular glands. Inhibition of 3H-QNB was then used to compare the anticholinergic activity of lofepramine, desipramine, imipramine and amitriptyline for muscarinic receptor in the salivary glands. The apparent dissociation constant (KD) for 3H-QNB binding in human parotid and rabbit submandibular gland was 33 and 61 pM and the Bmax value 507 and 169 f mol/mg protein, respectively. The mean values for the inhibition constant (Ki) for lofepramine, desipramine, imipramine and amitriptyline in human parotid gland were 285, 135, 102 and 13 nM, respectively. Very similar values were obtained for the rabbit submandibular gland. The binding affinity of tricyclic antidepressants for muscarinic cholinergic receptor sites in human parotid gland closely paralleled clinical data on the inhibition of salivary flow by these drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094050     DOI: 10.1007/bf00172861

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Antidepressants and the muscarinic acetylcholine receptor.

Authors:  S H Snyder; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1977-02

2.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

3.  The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors.

Authors:  P R Golds; F R Przyslo; P G Strange
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

4.  Comparison of peripheral anticholinergic effects of antidepressants: dry mouth.

Authors:  O J Rafaelsen; L Clemmesen; H Lund; P L Mikkelsen; T G Bolwig
Journal:  Acta Psychiatr Scand Suppl       Date:  1981

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  The effect of five tricyclic antidepressants on salivary flow and mood in healthy volunteers.

Authors:  B Blackwell; G R Peterson; R J Kuzma; R M Hostetler; A B Adolphe
Journal:  Commun Psychopharmacol       Date:  1980

7.  The pharmacological profile of lofepramine, a new antidepressant drug.

Authors:  C Sjögren
Journal:  Neuropharmacology       Date:  1980-12       Impact factor: 5.250

8.  Anticholinergic activity of two tricyclic antidepressants.

Authors:  B Blackwell; A Stefopoulos; P Enders; R Kuzma; A Adolphe
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

9.  Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain.

Authors:  E El-Fakahany; E Richelson
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

10.  [3H]oxotremorine-M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors.

Authors:  P Bevan
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

View more
  2 in total

1.  Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.

Authors:  K D Murugaiah; O E Ukponmwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-11       Impact factor: 3.000

Review 2.  Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  S G Lancaster; J P Gonzalez
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.